WHO ICTRP trial
Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells…
JPRN-UMIN000007525 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000007525 |
|---|---|
| Public title | Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells and activated killer cells in patients with resected primary lung cancer patients |
| Scientific title | Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells and activated killer cells in patients with resected primary lung cancer patients - Immunotherapy for post-surgical lung cancer patients |
| Primary sponsor | Chiba Cancer Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | Japan |
| Conditions | Primary lung cancer |
| Interventions | group A: immunotherapy and chemotherapy chemotherapy: CBDCA+GEM orCBDCA+PTX or CBDCA+PEM 4 courses every month 2 courses of Induction chemotherapy are applied for advanced cases Immunotherapy: every month for 6 courses and every 2 months… |
| Registration date | Jan 4, 2012 |
| Target size | 160 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: